Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiidra for ocular inflammation in cataract patients
NCT04120987Phase 4Withdrawn
- Sponsor
- Bucci Laser Vision Institute
- Start
- May 2021
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lifitegrast in dry eye syndrome (DED), sponsored by Bucci Laser Vision Institute. Planned start May 2021; status: withdrawn.
02
Drugs
lifitegrast
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT04120987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04120987.